Editors' picks from other sources

Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Hepatitis and HIV news

Show

From To
Access to medicines and treatment
Desperate patients turn to buyers clubs

What do you do when the NHS won’t buy the treatment you need?

Published
25 June 2019
From
The Economist (free registration required)
Side-effects
Preventing Drug Induced Liver Injury in Patients with HIV

With an estimated annual incidence rate of 13.9 to 24 per 100,000 inhabitants, drug-induced liver injury (DILI) the leading cause of acute liver failure in the United States. It is also a unique concern in people living with HIV. Recognizing the importance of comorbid HIV and DILI, researchers from Sacco University Hospital in Milano, Italy, have published a comprehensive review of the topic ahead-of-print in the journal Pharmacological Research.

Published
03 June 2019
From
Pharmacy Times
Vaccinations and immunisations
HIV-Related Factors Predict Reinforced Hepatitis B Vaccination Success

Certain characteristics and HIV-related factors may help predict whether certain demographics of people with HIV will have an optimal response to reinforced hepatitis B virus vaccination, according to an article published in Vaccine.

Published
03 June 2019
From
Infectious Disease Advisor
Retention and linkage to care
Cash Incentives, Peer Support May Not Incentivize HCV Treatment

A randomized trial comparing a cash incentive to peer support for increasing acceptance of treatment for hepatitis C virus (HCV) among persons with HCV/HIV coinfection, including those who use drugs or alcohol, found both methods helpful but that 1 in 4 patients still declined treatment.

Published
10 May 2019
From
MD Magazine
Elimination of hepatitis C
NHS trumpets Hep C deal, quietly drops 2025 elimination target after legal row

NHS England has announced a deal with AbbVie, Gilead, and Merck, Sharpe and Dohme (MSD) that aims to eliminate hepatitis C from the country – although it has had to drop a 2025 target date because of a legal row during the procurement process.

Published
30 April 2019
From
pharmaphorum
Elimination of hepatitis C
NHS England strikes world leading deal to help eliminate hepatitis C

The NHS will find and cure tens of thousands more people with hepatitis C as part of a ground-breaking deal that could help England become the first country in the world to eliminate the deadly virus.

Published
30 April 2019
From
NHS England
Vaccinations and immunisations
Previous HAV vaccination does not reliably protect some patients with HIV

Study findings suggest that previous vaccination against hepatitis A virus infection does not reliably protect some people with HIV.

Published
18 April 2019
From
Healio
Elimination of hepatitis C
England hits WHO 2020 hepatitis C target three years early

Deaths from liver disease related to serious hepatitis C (HCV) fell by more than 16% between 2015 and 2017, according to data published by Public Health England (PHE). As a result, England has hit the World Health Organization’s (WHO’s) target to reduce HCV related mortality by 10% by 2020 three years early.

Published
18 April 2019
From
The Pharmaceutical Journal
Hepatitis and HIV
Hepatic Steatosis Highly Prevalent in Young Adults With Lifelong HIV

One-third of young adults living with HIV since birth or early childhood have hepatic steatosis.

Published
17 April 2019
From
Infectious Disease Advisor
Elimination of hepatitis C
Health expert says hepatitis C could be eliminated quickly in Scotland

A leading expert in hepatitis C has said it could be removed from Scotland in the next five years if efforts to cure people were "energised".

Published
12 April 2019
From
BBC News
← First12345...155Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.